Outcomes of acute ischemic stroke and reperfusion therapy in patients with Moyamoya disease
Year: 2026
Type: article
Study design: Observational Study
Abstract: Moyamoya disease (MMD) is an uncommon cerebrovascular condition associated with acute ischemic stroke (AIS) and intracranial hemorrhage. This study examines outcomes of AIS in patients with MMD (MMD-AIS) and associated outcomes of endovascular thrombectomy (EVT) and intravascular thrombolysis (IVT). This retrospective cross-sectional analysis used the National Inpatient Sample database (2015–2022), including adult (≥18 years-old) U.S. hospitalizations for AIS with reported NIH Stroke Scale (NIHSS). Inverse probability of treatment weighting adjusted for confounding factors. Multivariable logistic regression estimated adjusted odds ratios (aORs) and 95% confidence intervals (CIs). Among 1,733,390 AIS hospitalizations, 3,735 (0.2%) involved comorbid MMD; 150 (4.0%) underwent EVT while 300 (8.0%) received IVT. MMD was associated with reduced use of EVT (aOR: 0.362, 95% CI [0.238–0.553], p < 0.001) and IVT (0.315 [0.242–0.412], p < 0.001) compared with non-MMD AIS. Following IPTW, MMD was associated with similar inpatient mortality (1.29 [0.797–2.09], p = 0.299), reduced routine discharge (0.639 [0.540–0.757], p < 0.001), and similar hemorrhagic transformation (1.13 [0.742–1.74], p = 0.560). Among the MMD-AIS group with NIHSS > 5, EVT was not associated with differences in routine discharge (0.672 [0.398–1.14], p = 0.137), inpatient mortality (0.072 [0.004–1.20], p = 0.067), or hemorrhagic transformation (1.61 [0.896–2.88], p = 0.111). IVT was associated with increased routine discharge (1.96 [1.35–2.85], p < 0.001), and no difference in hemorrhagic transformation (0.948 [0.542–1.66], p = 0.852) or mortality (1.74 [0.811–3.75], p = 0.155). MMD-AIS was associated with reduced routine discharge without increased hemorrhagic risk. EVT and IVT were infrequently used but may be feasible in selected patients. Prospective studies are needed to determine the efficacy of reperfusion therapy in this population.
Source: Figshare
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: moyamoya disease, acute ischemic stroke, mechanical thrombectomy, intravascular thrombolysis, reperfusion therapy, treatment utilization, in-hospital mortality, hemorrhagic transformation, NIHSS, stroke outcome, comorbidities, National Inpatient Sample, inverse probability of treatment weighting, hospital costs, health care costs, health care utilization
Open Access status: green
OpenAlex ID: W7227516771
